The incidence of endometrial cancer has been increasing, with up to 14% of cases occurring in women of reproductive age. Many younger women with endometrial cancer may not present with typical risk factors such as obesity or polycystic ovary syndrome (PCOS). Hysterectomy is considered the gold standard treatment for endometrial cancer; however, this is challenging for women who wish to preserve their fertility. Fertility‐sparing treatments can be offered in early‐stage disease with a favourable prognosis in women of reproductive age. Surveillance and compliance with treatment are paramount for positive treatment outcomes. We report a case of a woman who was diagnosed with endometrial cancer during in vitro fertilisation (IVF) treatment and subsequently achieved a live birth following complete disease regression with fertility‐sparing treatment. We discuss the importance of investigating women of reproductive age, especially those with a history of subfertility, and the provision of fertility‐sparing treatment.
Bhankharia et al. (Thu,) studied this question.